A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Mayo Clinic
Soligenix
City of Hope Medical Center
City of Hope Medical Center
Northwestern University
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Soligenix
OncoSec Medical Incorporated
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Soligenix
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
Northwestern University
Novartis
Novartis
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Takeda
Northwestern University
National Cancer Institute (NCI)
Mayo Clinic
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Helsinn Therapeutics (U.S.), Inc
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Bausch Health Americas, Inc.
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Mayo Clinic
Mayo Clinic